QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (186) Citing Articles via Google Scholar Google Scholar Articles by Nagayama, T. Articles by Greenberg, D. A. Search for Related Content PubMed PubMed Citation Articles by Nagayama, T. Articles by Greenberg, D. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 1999, 19(8):2987-2995

Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures

Tetsuya Nagayama¹, Amy D. Sinor^{1, 2}, Roger P. Simon¹, Jun Chen¹, Steven H. Graham¹, Kunlin Jin¹, and David A. Greenberg^{1, 2}

Departments of ¹ Neurology and ² Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213

Marijuana and related drugs (cannabinoids) have been proposed as treatments for a widening spectrum of medical disorders. R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazin-yl]-(1-naphthalenyl)methanone mesylate (R(+)-WIN 55212-2), a synthetic cannabinoid agonist, decreased hippocampal neuronal loss after transient global cerebral ischemia and reduced infarct volume after permanent focal cerebral ischemia induced by middle cerebral artery occlusion in rats. The less active enantiomer S()-WIN 55212-3 was ineffective, and the protective effect of R(+)-WIN 55212-2 was blocked by the specific central cannabinoid (CB₁) cannabinoid receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide-hydrochloride. R(+)-WIN 55212-2 also protected cultured cerebral cortical neurons from in vitro hypoxia and glucose deprivation, but in contrast to the receptor-mediated neuroprotection observed in vivo, this in vitro effect was not stereoselective and was insensitive to CB₁ and CB₂ receptor antagonists. Cannabinoids may have therapeutic potential in disorders resulting from cerebral ischemia, including stroke, and may protect neurons from injury through a variety of mechanisms.

Key words: cannabinoid; ischemia; stroke; glutamate; excitotoxicity; infarct; neuronal culture

---

Copyright © 1999 Society for Neuroscience  0270-6474/99/1982987-09$05.00/0

This article has been cited by other articles:

				H. J. Kim, J. J. Waataja, and S. A. Thayer Cannabinoids Inhibit Network-Driven Synapse Loss between Hippocampal Neurons in Culture J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 850 - 858. [Abstract] [Full Text] [PDF]

				A. Ludanyi, L. Eross, S. Czirjak, J. Vajda, P. Halasz, M. Watanabe, M. Palkovits, Z. Magloczky, T. F. Freund, and I. Katona Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus J. Neurosci., March 19, 2008; 28(12): 2976 - 2990. [Abstract] [Full Text] [PDF]

				P. Papathanasopoulos, L. Messinis, E. Lyros, A. Kastellakis, and G. Panagis Multiple Sclerosis, Cannabinoids, and Cognition J Neuropsychiatry Clin Neurosci, February 1, 2008; 20(1): 36 - 51. [Abstract] [Full Text] [PDF]

				T. P. Obrenovitch Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia Physiol Rev, January 1, 2008; 88(1): 211 - 247. [Abstract] [Full Text] [PDF]

				D. A. Karanian, S. L. Karim, J. T. Wood, J. S. Williams, S. Lin, A. Makriyannis, and B. A. Bahr Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1059 - 1066. [Abstract] [Full Text] [PDF]

				G. Cao, J. Xing, X. Xiao, A. K. F. Liou, Y. Gao, X.-M. Yin, R. S. B. Clark, S. H. Graham, and J. Chen Critical Role of Calpain I in Mitochondrial Release of Apoptosis-Inducing Factor in Ischemic Neuronal Injury J. Neurosci., August 29, 2007; 27(35): 9278 - 9293. [Abstract] [Full Text] [PDF]

				T. Aguado, E. Romero, K. Monory, J. Palazuelos, M. Sendtner, G. Marsicano, B. Lutz, M. Guzman, and I. Galve-Roperh The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis J. Biol. Chem., August 17, 2007; 282(33): 23892 - 23898. [Abstract] [Full Text] [PDF]

				S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey-White, A. Jafri, G. Hasko, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury FASEB J, June 1, 2007; 21(8): 1788 - 1800. [Abstract] [Full Text] [PDF]

				I. Galve-Roperh, T. Aguado, J. Palazuelos, and M. Guzman The Endocannabinoid System and Neurogenesis in Health and Disease Neuroscientist, April 1, 2007; 13(2): 109 - 114. [Abstract] [PDF]

				S. H. Kim, S. J. Won, X. O. Mao, C. Ledent, K. Jin, and D. A. Greenberg Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 150 - 154. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				L. G. Bilsland, J. R. T. Dick, G. Pryce, S. Petrosino, V. Di Marzo, D. Baker, and L. Greensmith Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice FASEB J, May 1, 2006; 20(7): 1003 - 1005. [Abstract] [Full Text] [PDF]

				A. Witting, L. Chen, E. Cudaback, A. Straiker, L. Walter, B. Rickman, T. Moller, C. Brosnan, and N. Stella From the Cover: Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection PNAS, April 18, 2006; 103(16): 6362 - 6367. [Abstract] [Full Text] [PDF]

				E. Shohami and R. Mechoulam Multiple sclerosis may disrupt endocannabinoid brain protection mechanism PNAS, April 18, 2006; 103(16): 6087 - 6088. [Full Text] [PDF]

				S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity Mol. Pharmacol., March 1, 2006; 69(3): 691 - 696. [Abstract] [Full Text] [PDF]

				D. A. Karanian, Q. B. Brown, A. Makriyannis, T. A. Kosten, and B. A. Bahr Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity J. Neurosci., August 24, 2005; 25(34): 7813 - 7820. [Abstract] [Full Text] [PDF]

				D. J. Rademacher, S. Patel, W.-S. V. Ho, A. M. Savoie, N. J. Rusch, K. M. Gauthier, and C. J. Hillard U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2694 - H2701. [Abstract] [Full Text] [PDF]

				S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 88 - 94. [Abstract] [Full Text] [PDF]

				B. G. Ramirez, C. Blazquez, T. G. del Pulgar, M. Guzman, and M. L. de Ceballos Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation J. Neurosci., February 23, 2005; 25(8): 1904 - 1913. [Abstract] [Full Text] [PDF]

				K. Jin, L. Xie, S. H. Kim, S. Parmentier-Batteur, Y. Sun, X. O. Mao, J. Childs, and D. A. Greenberg Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice Mol. Pharmacol., August 1, 2004; 66(2): 204 - 208. [Abstract] [Full Text] [PDF]

				T. Geller, L. Loftis, and D. S. Brink Cerebellar Infarction in Adolescent Males Associated With Acute Marijuana Use Pediatrics, April 1, 2004; 113(4): e365 - e370. [Abstract] [Full Text] [PDF]

				D. Amtmann, P. Weydt, K. L. Johnson, M. P. Jensen, and G. T. Carter Survey of cannabis use in patients with amyotrophic lateral sclerosis American Journal of Hospice and Palliative Medicine, March 1, 2004; 21(2): 95 - 104. [Abstract] [PDF]

				A. B. El-Remessy, I. E. Khalil, S. Matragoon, G. Abou-Mohamed, N.-J. Tsai, P. Roon, R. B. Caldwell, R. W. Caldwell, K. Green, and G. I. Liou Neuroprotective Effect of(-){Delta}9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-D-Aspartate-Induced Retinal Neurotoxicity: Involvement of Peroxynitrite Am. J. Pathol., November 1, 2003; 163(5): 1997 - 2008. [Abstract] [Full Text] [PDF]

				G. Pryce, Z. Ahmed, D. J. R. Hankey, S. J. Jackson, J. L. Croxford, J. M. Pocock, C. Ledent, A. Petzold, A. J. Thompson, G. Giovannoni, et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis Brain, October 1, 2003; 126(10): 2191 - 2202. [Abstract] [Full Text] [PDF]

				A. Franklin, S. Parmentier-Batteur, L. Walter, D. A. Greenberg, and N. Stella Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility J. Neurosci., August 27, 2003; 23(21): 7767 - 7775. [Abstract] [Full Text] [PDF]

				R. R. Leker, N. Gai, R. Mechoulam, and H. Ovadia Drug-Induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210 Stroke, August 1, 2003; 34(8): 2000 - 2006. [Abstract] [Full Text] [PDF]

				F. Molina-Holgado, E. Pinteaux, J. D. Moore, E. Molina-Holgado, C. Guaza, R. M. Gibson, and N. J. Rothwell Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia J. Neurosci., July 23, 2003; 23(16): 6470 - 6474. [Abstract] [Full Text] [PDF]

				L. Iversen Cannabis and the brain Brain, June 1, 2003; 126(6): 1252 - 1270. [Abstract] [Full Text] [PDF]

				W. B. Veldhuis, M. van der Stelt, M. W. Wadman, G. van Zadelhoff, M. Maccarrone, F. Fezza, G. A. Veldink, J. F. G. Vliegenthart, P. R. Bar, K. Nicolay, et al. Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil against In Vivo Excitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases J. Neurosci., May 15, 2003; 23(10): 4127 - 4133. [Abstract] [Full Text] [PDF]

				E. Molina-Holgado, J. M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, J. Borrell, and C. Guaza Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling J. Neurosci., November 15, 2002; 22(22): 9742 - 9753. [Abstract] [Full Text] [PDF]

				S. Parmentier-Batteur, K. Jin, X. O. Mao, L. Xie, and D. A. Greenberg Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice J. Neurosci., November 15, 2002; 22(22): 9771 - 9775. [Abstract] [Full Text] [PDF]

				S. Parmentier-Batteur, K. Jin, L. Xie, X. O. Mao, and D. A. Greenberg DNA Microarray Analysis of Cannabinoid Signaling in Mouse Brain in Vivo Mol. Pharmacol., October 1, 2002; 62(4): 828 - 835. [Abstract] [Full Text] [PDF]

				T. Gomez del Pulgar, M. L. de Ceballos, M. Guzman, and G. Velasco Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway J. Biol. Chem., September 20, 2002; 277(39): 36527 - 36533. [Abstract] [Full Text] [PDF]

				W.-R. Schabitz, A. Giuffrida, C. Berger, A. Aschoff, M. Schwaninger, S. Schwab, and D. Piomelli Release of Fatty Acid Amides in a Patient With Hemispheric Stroke: A Microdialysis Study Stroke, August 1, 2002; 33(8): 2112 - 2114. [Abstract] [Full Text] [PDF]

				F. Mauler, J. Mittendorf, E. Horvath, and J. de Vry Characterization of the Diarylether Sulfonylester (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 359 - 368. [Abstract] [Full Text] [PDF]

				R. Mechoulam, M. Spatz, and E. Shohami Endocannabinoids and Neuroprotection Sci. Signal., April 23, 2002; 2002(129): re5 - re5. [Abstract] [Full Text] [PDF]

				M. van der Stelt, W. B. Veldhuis, G. W. van Haaften, F. Fezza, T. Bisogno, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, V. Di Marzo, and K. Nicolay Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo J. Neurosci., November 15, 2001; 21(22): 8765 - 8771. [Abstract] [Full Text] [PDF]

				M. van der Stelt, W. B. Veldhuis, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, and K. Nicolay Neuroprotection by {Delta}9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity J. Neurosci., September 1, 2001; 21(17): 6475 - 6479. [Abstract] [Full Text] [PDF]

				G. T. Carter and B. S. Rosen Marijuana in the management of amyotrophic lateral sclerosis American Journal of Hospice and Palliative Medicine, July 1, 2001; 18(4): 264 - 270. [Abstract] [PDF]

				G. Cao, W. Pei, J. Lan, R. A. Stetler, Y. Luo, T. Nagayama, S. H. Graham, X.-M. Yin, R. P. Simon, and J. Chen Caspase-Activated DNase/DNA Fragmentation Factor 40 Mediates Apoptotic DNA Fragmentation in Transient Cerebral Ischemia and in Neuronal Cultures J. Neurosci., July 1, 2001; 21(13): 4678 - 4690. [Abstract] [Full Text] [PDF]

				B. Moesgaard, G. Petersen, J. W. Jaroszewski, and H. S. Hansen Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain: a 31P NMR and enzyme activity study J. Lipid Res., June 1, 2000; 41(6): 985 - 990. [Abstract] [Full Text]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help